## FCX: Freeport-McMoRan Inc. - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 7.2% in mid entry zone (4.0-10.0%), top 3% cross-sectional ranking. Short-term MRS_5 (1.1%) confirms momentum alignment. Outperforming sector by 4.0%. Caution: momentum weakening (-4.3% MRS), overbought RSI (70).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($49.03)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 4)

**1. Freeport-McMoRan Inc. Class Action: The Gross Law Firm Reminds Freeport-McMoRan Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026 â€“ FCX**
- Source: FOX4KC.com | 20260101T080809 | Bearish | Relevance: 100%
- The Gross Law Firm has issued a notice to investors of Freeport-McMoRan Inc. (NYSE: FCX) regarding a class action lawsuit. Shareholders who purchased FCX shares between February 15, 2022, and September 24, 2025, are encouraged to contact the firm, as the company allegedly made false or misleading statements concerning safety at its Grasberg Block Cave mine. The deadline for investors to seek appointment as lead plaintiff is January 12, 2026.

**2. Freeport-McMoRan Inc. Class Action: The Gross Law Firm**
- Source: GlobeNewswire | 20251231T211155 | Bearish | Relevance: 100%
- The Gross Law Firm has issued a notice to shareholders of Freeport-McMoRan Inc. (NYSE: FCX) regarding a pending class action lawsuit. This action alleges that Freeport-McMoRan made materially false and/or misleading statements concerning safety at its Grasberg Block Cave mine in Indonesia. Shareholders who purchased FCX shares between February 15, 2022, and September 24, 2025, are encouraged to contact the firm, with a lead plaintiff deadline of January 12, 2026.

**3. Freeport-McMoRan Inc. Class Action: The Gross Law Firm**
- Source: GlobeNewswire | 20251231T210817 | Bearish | Relevance: 100%
- The Gross Law Firm has issued a notice to shareholders of Freeport-McMoRan Inc. (NYSE: FCX) regarding a pending class action lawsuit. Shareholders who purchased shares between February 15, 2022, and September 24, 2025, are encouraged to contact the firm, with a lead plaintiff deadline of January 12, 2026. The lawsuit alleges that Freeport-McMoRan made materially false and misleading statements concerning safety at its Grasberg Block Cave mine, leading to undisclosed regulatory, litigation, and reputational risks.

**4. Freeport-McMoRan Inc. stock outperforms competitors despite losses on the day**
- Source: MarketWatch | 20251231T164300 | Somewhat-Bearish | Relevance: 100%
- Freeport-McMoRan Inc. (FCX) shares fell by 1.21% to $50.79 on Wednesday, marking its third consecutive day of losses. This occurred during an overall negative trading session where the S&P 500 Index (SPX) dropped 0.74% and the Dow Jones Industrial Average (DJIA) fell 0.63%. Despite its own decline, the stock's performance still managed to outpace that of its competitors.

**5. Freeport-McMoRan (NYSE:FCX) Price Target Raised to $53.00 at Raymond James Financial**
- Source: MarketBeat | 20251231T143954 | Somewhat-Bullish | Relevance: 100%
- Raymond James Financial has raised its price target for Freeport-McMoRan (NYSE:FCX) to $53.00 from $49.00, reiterating an "outperform" rating, which suggests a 3.45% upside from its previous close. This update comes as the natural resource company recently surpassed quarterly earnings and revenue estimates. Despite some mixed revisions from other analysts, the consensus remains a "Buy" with an average target price of $49.87.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Wells Fargo | $55 | $47 | +17% |
| 2025-12-12 | UBS | $60 | $55 | +9% |
| 2025-12-05 | JP Morgan | $58 | $50 | +16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Wells Fargo | main | Overweight |
| 2025-12-12 | UBS | main | Buy |
| 2025-12-05 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($1.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation risk: PEG 4.5x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +14%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 4.54 signals overvaluation risk, limited margin of safety. Forward P/E 22.5x attractive for 50% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment positive (3 raises, avg +14%). Insider selling cluster ($1.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $74.6B |
| Beta | 1.48 |
| 52W Range | $27.66 - $53.77 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.54 |
| Forward P/E | 22.5 |
| Current P/E | 33.6 |
| YoY Growth | 49.7% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 11.5% to 7.2% (-4.3% in 5 days), indicating relative weakness vs NASDAQ. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 97th percentile. MRS_5 at 1.1% confirms short-term momentum alignment. AM_20 at 6.6% shows strong absolute momentum above own 20MA. Outperforming sector by 4.0pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 70, risk of mean reversion. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 7.17% (CS: 97) | Strong |
| RSI_14 | 70.4 | Overbought |
| MACD Histogram | 0.10 | Bullish |
| vs SMA20 | 1.066x | Above |
| vs SMA50 | 1.176x | Above |
| vs SMA200 | 1.248x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $51.93
- **Stop Loss:** $49.03 (5.6% risk)
- **Target:** $56.28 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 496
- **Position Value:** $25,757.28
- **Portfolio %:** 25.76%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*